NGF and stroke disorder: Blocking transient receptor potential vanilloid 2 (TRPV2) in astrocytes has been reported to increase astrocyte proliferation, nerve growth factor (NGF) mRNA synthesis, and NGF secretion, which have neuroprotective effects in the early stages of stroke [139].